INTERVENTIONAL CARDIOLOGY: ATHERECTOMY AND THROMBOEMBOLECTOMY

100 Pages | 54 Exhibits | 2018 Analysis | Forecasts Through 2022

OVERVIEW:
This analysis includes a discussion of products, competitiors, market forecasts, and opportunities in the global market for atherectomy and thromboembolectomy products.

INTERVENTIONAL CARDIOLOGY: ATHERECTOMY AND THROMBOEMBOLECTOMY MARKET HIGHLIGHTS

  • Total unit sales for atherectomy and thromboembolectomy products are steadily increasing due to a number of factors, including: the increasing prevalence of CVD, advances in CVD diagnostics, and demand for minimally invasive interventional therapies to treat patients requiring surgical interventions to manage their conditions.
  • In 2016, embolectomy and thrombectomy products accounted for the majority of total atherectomy and thromboembolectomy device sales. Thrombectomy devices are forecast to experience the strongest growth in terms of total unit sales throughout the forecast period.
  • The global market for atherectomy and thromboembolectomy devices is anticipated to increase at a CAGR of 7.8% during the forecast period (2016-22), reaching approximately $2,724.5m in total product sales by 2022.
  • The US was the largest market for atherectomy and thromboembolectomy products accounted for approximately 51% of all product sales in 2016, followed by the five major EU markets. Meddevicetracker estimates that the rest of the world (RoW) segment will see the strongest growth throughout the forecast period.
  • Mechanical thrombectomy devices for the treatment of acute ischemic stroke have the highest potential for growth as a result of recent clinical trial data and an underserved patient population.
Topics Covered Include:
  • An overview of atherectomy, embolectomy, and thrombectomy products used in the debulking of heavily calcified lesions commonly associated with more severe cases of cardiovascular disease.
  • Global and country/region-specific market forecasts, including forecasts by product segment.
  • Competitive analyses by product segment.
  • Discussion of key drivers and limiters impacting the major product segments.
  • Primary reaearch with interventional cardiologists from the US, five major EU markets, and Japan focused on how physicians are utilizing these devices and their preferred/most frequently utilized manufacturers.
  • A review of emerging technologies which could impact sales of existing devices.


TABLE OF CONTENTS:
Executive Summary
 
i. Cardiovascular diseases overview
ii. Global atherectomy and thrombectomy devices market
	a. Market drivers and limiters
	b. Device segment insights 
	c. Technology trends
	d. Market leaders
	e. Competitive strategies
	f. Emerging competition 
iii. Methodology

Exhibit ES-1: Atherectomy and thrombectomy devices, global market forecast, 2016-22
Exhibit ES-2: Global atherectomy and thrombectomy products market, share by country/region, 2016 
Exhibit ES-3: Drivers and limiters of growth - atherectomy and thrombectomy devices 

1. Cardiovascular Diseases Overview
 
1.1 Acute coronary syndrome
	1.1.1 Atherosclerosis 
	1.1.2 Angina pectoris
	1.1.3 Myocardial infarction
	1.1.4 Diagnosis and treatment
1.2 Hypertension
1.3 Peripheral vascular disease
	1.3.1 Critical limb ischemia 
	1.3.2 Aneurysm
	1.3.3 Deep vein thrombosis/pulmonary embolism
	1.3.4 Diagnosis and treatment
1.4 Cerebrovascular disease 
	1.4.1 Diagnosis and treatment
1.5 Bibliography 

Exhibit 1-1: Estimated mortality due to ischemic heart disease and cerebrovascular disease, select countries 
Exhibit 1-2: Top 10 countries with the highest CVD death rates
Exhibit 1-3: Estimated incident cases for acute coronary syndrome, select countries
Exhibit 1-4: Age-standardized incidence (per 100,000) of angina pectoris, select regions
Exhibit 1-5: Clinical classification of acute myocardial infarction
Exhibit 1-6: Age-standardized incidence (per 100,000) of acute myocardial infarction, select regions
Exhibit 1-7: Estimated incident cases of myocardial infarction, select countries 
Exhibit 1-8: Estimated prevalent cases of hypertension, select countries
Exhibit 1-9: Mortality attributable to hypertensive diseases, select countries
Exhibit 1-10: Estimated incident cases of DVT, select countries
Exhibit 1-11: Estimated incident cases of PE, select countries
Exhibit 1-12: Estimated incident cases of ischemic stroke, select countries
Exhibit 1-13: Estimated incident cases of hemorrhagic stroke, select countries
Exhibit 1-14: Estimated prevalent cases of ischemic stroke, select countries 
Exhibit 1-15: Estimated prevalent cases of hemorrhagic stroke, select countries

2. Atherectomy and Thromboembolectomy Products

2.1 Atherectomy 
	2.1.1 Atherectomy products
	2.1.2 Atherectomy devices in development
2.2 Catheter-based thromboembolectomy
	2.2.1 Thrombectomy/embolectomy products 
	2.2.2 Embolectomy/thrombectomy products in development
2.3 Innovation in minimally invasive interventional cardiology devices
2.4 Bibliography 

Exhibit 2-1: Advantages and disadvantages of atherectomy
Exhibit 2-2: Selected atherectomy devices and manufacturers
Exhibit 2-3: Selected ongoing clinical trials investigating atherectomy devices
Exhibit 2-4: Selected embolectomy and thrombectomy systems and their manufacturers
Exhibit 2-5: Selected ongoing clinical trials investigating embolectomy/thrombectomy devices

3. Atherectomy and Thrombectomy Market
 
3.1 Global market insights
	3.1.1 Market value
	3.1.2 Technology trends 
	3.1.3 Market drivers and limiters 
	3.1.4 Atherectomy devices overview
	3.1.5 Thrombectomy devices overview
	3.1.6 Market leaders
	3.1.7 Competitive strategies
	3.1.8 Emerging competition 
3.2 Global competitors 
	3.2.1 Atherectomy devices
	3.2.2 Thrombectomy devices
3.3 Market forecast
	3.3.1 Market forecast: US 
	3.3.2 Market forecast: five major EU markets
	3.3.3 Market forecast: Japan 
	3.3.4 Market forecast: Rest of the World
3.4 Bibliography 

Exhibit 3-1: Atherectomy and thrombectomy devices, global market forecast, 2016-22 
Exhibit 3-2: Atherectomy and thrombectomy device sales, combined market forecast ($m), by product segment, 2016-22 
Exhibit 3-3: Global atherectomy and thrombectomy products market, share by country/region, 2016 
Exhibit 3-4: Global atherectomy and thrombectomy product sales, combined market forecast ($m), by country/region, 2016-22 
Exhibit 3-5: Drivers and limiters of growth - atherectomy and thrombectomy devices
Exhibit 3-6: Atherectomy, procedure volumes forecast (000s), select countries/regions, 2016-22 
Exhibit 3-7: Thrombectomy, procedure volumes forecast (000s), select countries/regions, 2016-22 
Exhibit 3-8: Global atherectomy market, share by supplier, 2016 
Exhibit 3-9: Global thrombectomy market, share by supplier, 2016
Exhibit 3-10: US atherectomy, procedure volumes forecast (000s), 2016-22
Exhibit 3-11: US thrombectomy, procedure volumes forecast (000s), 2016-22 
Exhibit 3-12: US atherectomy and thrombectomy device sales, combined market forecast ($m), by product segment, 2016-22 
Exhibit 3-13: US atherectomy devices market forecast ($m), 2016-22
Exhibit 3-14: US atherectomy devices market, share by supplier, 2016 
Exhibit 3-15: US thrombectomy devices market forecast ($m), 2016-22 
Exhibit 3-16: US thrombectomy devices market, share by supplier, 2016
Exhibit 3-17: 5EU atherectomy, procedure volumes forecast (000s), 2016-22
Exhibit 3-18: 5EU thrombectomy, procedure volumes forecast (000s), 2016-22 
Exhibit 3-19: 5EU atherectomy and thrombectomy device sales, combined market forecast ($m), by product segment, 2016-22
Exhibit 3-20: 5EU atherectomy devices market forecast ($m), 2016-22
Exhibit 3-21: 5EU atherectomy devices market, share by supplier, 2016 
Exhibit 3-22: 5EU thrombectomy devices market forecast ($m), 2016-22 
Exhibit 3-23: 5EU thrombectomy devices market, share by supplier, 2016
Exhibit 3-24: Japan atherectomy, procedure volumes forecast (000s), 2016-22
Exhibit 3-25: Japan thrombectomy, procedure volumes forecast (000s), 2016-22 
Exhibit 3-26: Japan atherectomy and thrombectomy device sales, combined market forecast ($m), by product segment, 2016-22
Exhibit 3-27: Japan atherectomy devices market forecast ($m), 2016-22
Exhibit 3-28: Japan thrombectomy devices market forecast ($m), 2016-22
Exhibit 3-29: RoW atherectomy and thrombectomy device sales, combined market forecast ($m), by product segment, 2016-22
Exhibit 3-30: RoW atherectomy devices market forecast ($m), 2016-22 
Exhibit 3-31: RoW thrombectomy devices market forecast ($m), 2016-22

Appendix: Company Listing


COMPANIES COVERED:

  1. Accura
  2. Argon Medical Devices
  3. Avinger
  4. BD
  5. BIOTRONIK
  6. Boston Scientific
  7. BTG
  8. C.R. Bard/BD
  9. Capture Vascular
  10. CardioProlific/Philips
  11. Cardiovascular Systems
  12. Control Medical Technology
  13. DISA Vascular
  14. Edwards Lifesciences
  15. Endocor
  16. eucatech
  17. Eurocor/Opto Circuits Group
  18. Eximo Medical
  19. Inari Medical
  20. iVascular
  21. JIMRO
  22. Kaneka Medical Products
  23. LeMaitre Vascular
  24. Medtronic
  25. Merit Medical Systems
  26. Natec Medical
  27. Neuravi
  28. Philips
  29. Penumbra
  30. Ra Medical Systems
  31. Rex Medical
  32. SIS Medical/Schwager Medica
  33. STENTYS
  34. Spectranetics/Philips
  35. Straub Medical
  36. Stryker
  37. Teleflex
  38. Terumo Interventional Systems
  39. Walk Vascular
  40. Zhuhai Tonbridge Medical Tech
Contact Us

Need help finding medtech research? Let us help you!